Log in
Enquire now
‌

Immune Response Following COVID-19 in Hemodialysis Patients

OverviewStructured DataIssuesContributors

Contents

clinicaltrials.gov/study/NCT05307601
Is a
‌
Clinical study
0

Clinical Study attributes

NCT Number
NCT053076010
Health Conditions in Trial
COVID-19
COVID-19
0
‌
Cytokine storm
0
Trial Recruitment Size
210
Clinical Trial Start Date
September 1, 2020
0
Primary Completion Date
September 1, 2021
0
Study Completion Date
October 30, 2021
0
Clinical Trial Study Type
Observational0
Observational Clinical Trial Type
Cohort0
Observational Study Perspective
Prospective0
Official Name
Evaluation of the Cytokine 's Profile Following SarsCov 2 Infection (COVID-19) in Hemodialysis Patients0
Last Updated
April 1, 2022
0
Study summary

Patients with chronic kidney disease (CKD), particularly those undergoing hemodialysis (HD), are at high risk of a severe form of COVID-19. This study aims to characterize the inflammatory and antiviral response during SarsCov2 infection in adult

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like Immune Response Following COVID-19 in Hemodialysis Patients

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.